The HEARTWISE study is a ground-breaking research initiative aimed at enhancing cardiovascular care delivery within the Hong Kong public healthcare system. As a key part of the P-CARDIAC project's implementation phase, this study examines the effectiveness and feasibility of a novel care model.
We are investigating whether pharmacists, supported by the AI-powered P-CARDIAC Score for risk assessment, can effectively manage patients with stable cardiovascular risks. The goal is to provide timely, personalized care while potentially reducing wait times for specialist appointments and optimizing the use of healthcare resources.
HEARTWISE research team is actively recruiting participants to help us evaluate this new approach. Your participation can contribute significantly to improving healthcare services for the community.
Exclusion criteria: People with history of dementia, psychiatric disease or physical impairment will be excluded in this study (detailed criteria available upon inquiry).
If you are interested in joining the HEARTWISE study and meet the eligibility criteria, please click Register Online or contact our research team.
Register Online